ELIZABETH LEIBFREID: Open Payments
NPI 1558122622 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 18 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $625 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Haemonetics Corporation | 1 | $159 |
| Gilead Sciences, Inc. | 1 | $125 |
| Medtronic, Inc. | 1 | $101 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Vifor Pharma, Inc. | 2 | $30 |
| Veloxis Pharmaceuticals, Inc. | 2 | $30 |
| Acera Surgical, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: TEG6S HEMOSTASIS SYSTEM, EMPRINT, REZDIFFRA, IQIRVO, Veltassa, ENVARSUS, Restrata Wound Matrix, PREVENA.
Industry payments across NJ — which companies pay providers there.
